DelveInsight's "Crohn’s Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth ...

Mark Bodmer and Jonathan Lewis of UCB pharma talk us though the partnering model at UCB, and how partnering can drive innovation. The world is changing and it’s no different for the ...

Swansea University has helped secure £22.4 million in funding from the Biotechnology and Biological Sciences Research Council ...

Problems with cognition, memory, and emotional regulation may persist for 3 years or more after a diagnosis of anti-NMDAR ...

UCB and Biogen say their first phase 3 trial ... syndrome listed in Novartis' latest pipeline update. The AI effect in pharma commercial strategy: From data to re... Discover how AI is ...

Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...

Verrica Pharmaceuticals priced its public offering at $42 million ... The WHO added LC16M8 mpox vaccine to its emergency use ...

One year after replacement with zoledronate, reversals of denosumab’s gains in lumbar spine BMD are seen — with longer ...

ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) and West Pharmaceutical Services (NYSE:WST – Get Free Report) are both medical companies, but which is the superior business? We will compare the two ...

The stock market in Bangladesh extended a losing streak for a third consecutive trading day yesterday as skittish investors ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

Major indices of the stock market in Bangladesh rose marginally yesterday, breaking a three-day losing streak, as investors cautiously traded selective shares to make short-term gains amid price ...